The botulism illness market is expected to show a CAGR of 6.4% during the forecast period. Botulism illness infections are caused by a Gram-positive, rod-shaped bacteria named as Clostridium Botulinum, which produces an extremely lethal substance under low oxygen conditions that is botulinum neurotoxin. Ingestion of this toxin body leads to life-threatening neuroparalysis and can be deadly. It blocks the motor nerve terminal at the myoneural junction and causes flaccid paralysis. This disease is caused by ingestion of bacteria in any form due to exposure to contaminated soil, water or canned foods, meat, fish, mushrooms, and spinach. The market for botulism illness is expanding worldwide due to driving factors such as increasing incidence of botulism, advancement in the area of medical technologies, government initiatives supporting research and development in the clinical health sector, and availability of favorable reimbursement policies. However, high capital investments required for treatment and wrong and late diagnosis of the disease are hindering the growth of the botulism illness market. Lack of awareness about the disease, unavailability of proper healthcare infrastructure, and unaffordability in middle-income countries are the major challenges to the market.
Market Players
Allergan Inc
Pfizer Inc.
Alphavax, Inc
Microbiotix, Inc
Molecular Targeting Technologies, Inc
Ipsen Technologies Pvt. Ltd
Galderma S. A
Canbex therapeutics ltd
Azidus
Market Segmentation
The global botulism illness market is segmented on the basis of toxin type, treatment type, drug distribution channel, and end-user. Considering toxin type, the market is segmented into botulinum type A and botulinum type B.
By treatment, the market is segmented into antitoxins, meticulous airway management, cathartics, Foley catheter, and others. Based on anti-toxin, the market is again segmented into trivalent antitoxin and heptavalent botulinum antitoxin.
With reference to distribution channel, the market is segmented into retail pharmacy and online stores.
On account of end-users, the market is segmented into hospitals and clinics and others.
Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Market Segmentation & Key players
Global Botulism Illness Market, by Toxin type
- Botulinum Type A
- Botulinum Type B
Global Botulism Illness Market, by Treatment type
- Antitoxins
- Trivalent Antitoxin
- Heptavalent Botulinum Antitoxin
- Meticulous airway management
- Cathartics
- Foley catheter
- Others
Global Botulism Illness Market, by Drug Distribution Channel
- Retail Pharmacy
- Online Stores
Botulism Illness Market, By End-User
- Hospitals & Clinics
- Others
Request Customization
Get a Sample
Get a Sample
Request Customization